Neurocrine Biosciences Inc (NASDAQ:NBIX)

119.13
Delayed Data
As of May 27
 +0.22 / +0.19%
Today’s Change
72.14
Today|||52-Week Range
128.29
+10.83%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close118.89
Today’s open118.06
Day’s range112.27 - 119.59
Volume1,261,243
Average volume (3 months)833,768
Market cap$11.6B
Data as of 4:00pm ET, 05/27/2020

Growth & Valuation

Earnings growth (last year)+72.61%
Earnings growth (this year)+691.28%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+74.65%
P/E ratio62.7
Price/Sales13.06
Price/Book18.09

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-3.38-1.30%
EXASExact Sciences Corp+1.30+1.61%
IMMUImmunomedics Inc+0.07+0.21%
ALLOAllogene Therapeutic...-0.36-0.73%
Data as of 4:58pm ET, 05/27/2020

Financials

Next reporting dateJuly 29, 2020
EPS forecast (this quarter)$0.70
Annual revenue (last year)$788.1M
Annual profit (last year)$37.0M
Net profit margin4.70%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts